🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aortic stenosis (AS) is the most frequent valvulopathy in Western countries...
Status
Completed
Location
Brest University Hospital
Start Date
2022-10-26
Trial ID
NCT05237804
Treatments Being Tested
The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 w...
Status
Recruiting
Location
Cedars-Sinai Women's Heart Center
Start Date
2015-10
Trial ID
NCT02582021
The study is designed to evaluate the predictive diagnostic accuracy of Son...
Status
Completed
Location
North Shore University Hospital
Start Date
2010-01
Trial ID
NCT01040923
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
To determine the relative efficacy of Cardiac Computed Tomography Angiograp...
Status
Terminated
Location
GE Healthcare
Start Date
2007-06
Trial ID
NCT00486447
Treatments Being Tested
This phase II trial tests how well nemtabrutinib in combination with pembro...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-08-15
Trial ID
NCT06863402
After having had a first cardiovascular event, there is a considerable risk...
Status
Unknown
Location
UMC Utrecht
Start Date
2012-08
Trial ID
NCT01932671
This phase II trial tests how well zanzalintinib (XL092) works in treating ...
Status
Recruiting
Location
Northwestern University
Start Date
2024-09-19
Trial ID
NCT06571734
This phase II trial compares the effect of usual treatment of docetaxel che...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-03
Trial ID
NCT05408845